Evidence map›Paper›PMID 37747317›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

IL-15 Priming Alters IFN-γ Regulation in Murine NK Cells.

Maria Cimpean, Molly P Keppel, Anastasiia Gainullina, Changxu Fan, Hyogon Sohn, Nathan C Schedler, Amanda Swain, Ana Kolicheski, Hannah Shapiro, Howard A Young and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Immunology of Cytokine Storm Syndromes: Natural Killer Cells.Advances in experimental medicine and biology · 2024
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Maria CimpeanDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-3735-2643
Molly P KeppelDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Anastasiia GainullinaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-3796-2337
Changxu FanDepartment of Genetics, Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-4375-4019
Hyogon SohnDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-8103-1551
Nathan C SchedlerDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Amanda SwainDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Ana KolicheskiDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-7084-5119
Hannah ShapiroDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Howard A YoungCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD.ORCID 0000-0002-3118-5111
Ting WangDepartment of Genetics, Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-6800-242X
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-1133-4212
Megan A CooperDivision of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-5696-172X
Washington University in St. Louis · USFrederick National Laboratory for Cancer Research · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
METABOLIC REGULATION OF NATURAL KILLER CELL ACTIVATIONR01AI127752 · NIAID · WASHINGTON UNIVERSITY · PI COOPER, MEGAN ANNE · 2017 to 2021
$1.9M
Metabolic Regulation of Natural Killer Cell ActivationR56AI127752 · NIAID · WASHINGTON UNIVERSITY · PI COOPER, MEGAN ANNE · 2023 to 2023
$300k
NCATS NIH HHS UL1 TR000448NCI NIH HHS P30 CA091842NIAID NIH HHS R01 AI127752NIAID NIH HHS R56 AI127752
6 · The paper itself

Abstract

NK effector functions can be triggered by inflammatory cytokines and engagement of activating receptors. NK cell production of IFN-γ, an important immunoregulatory cytokine, exhibits activation-specific IFN-γ regulation. Resting murine NK cells exhibit activation-specific metabolic requirements for IFN-γ production, which are reversed for activating receptor-mediated stimulation following IL-15 priming. Although both cytokine and activating receptor stimulation leads to similar IFN-γ protein production, only cytokine stimulation upregulates Ifng transcript, suggesting that protein production is translationally regulated after receptor stimulation. Based on these differences in IFN-γ regulation, we hypothesized that ex vivo IL-15 priming of murine NK cells allows a switch to IFN-γ transcription upon activating receptor engagement. Transcriptional analysis of primed NK cells compared with naive cells or cells cultured with low-dose IL-15 demonstrated that primed cells strongly upregulated Ifng transcript following activating receptor stimulation. This was not due to chromatin accessibility changes in the Ifng locus or changes in ITAM signaling, but was associated with a distinct transcriptional signature induced by ITAM stimulation of primed compared with naive NK cells. Transcriptional analyses identified a common signature of c-Myc (Myc) targets associated with Ifng transcription. Although Myc marked NK cells capable of Ifng transcription, Myc itself was not required for Ifng transcription using a genetic model of Myc deletion. This work highlights altered regulatory networks in IL-15-primed cells, resulting in distinct gene expression patterns and IFN-γ regulation in response to activating receptor stimulation.

Indexed as

Interleukin-15Killer Cells, NaturalAnimalsCytokinesInterferon-gammaMiceSignal TransductionCytokinesIFNG protein, mouseInterferon-gammaInterleukin-15

Identifiers

PMID37747317
PMCPMC10873103
OpenAlexW4387001985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.